 |
Stoke Therapeutics
Last updated: October 09, 2024
Founders: Isabel Aznarez, Adrian Krainer
USA | Funding: $360.1M (+)
Website: https://www.stoketx.com
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
Website: https://www.stoketx.com
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
